United States · 
What does OMX Ventures invest in?
OMX Ventures invests most often at Series A and Seed (75% of the rounds on record), in sectors such as Biotech, Therapeutics and Synthetic Bio.
OMX Ventures highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A and Seed: 75% of its rounds
- 03
Led 2 rounds
What they do
Using a technology-first approach, OMX takes groundbreaking discoveries and grows them into scalable biotech companies on both sides of the Atlantic.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $500K – $15M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- BiotechTherapeuticsSynthetic Bio
- Based in
- Chicago, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first4 appearances
- 2026
1 round
- Apr
- 2025
1 round
- Jun
- 2024
1 round
- Sept
- 2022
1 round
- Aug
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
ACAnthony Craig AsherMANAGER OF ISSUER'S MANAGERiFiling they signed
DCDaniel Craig FeroMANAGER OF ISSUER'S MANAGERiFiling they signed
JSJohn Stanley NawrockiChief Financial OfficeriForm ADV
NGNicholas Gabriel HaftMANAGER OF ISSUER'S MANAGERiFiling they signed
We also hold 14 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$253Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- OMX Ventures, LLC
- SEC number
- CRD 313397
What they claim to have backed
From their own portfolio page (on their website)
1 of 4 we have independently watched raise
10x Genomics 1-colorGinkgo Bioworks Logo 1-colorTwist Bioscience Logo 1-colorXeris Biopharma Logo 1-color
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.